ICON Public Limited Company (ICLR)

315,46 -1,39 (-0,44%) Alla chiusura: 04:00PM EDT

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin D18 X5R3
Ireland
353 1 291 2000
https://www.iconplc.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 41.150

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Steven A. Cutler MBA, Ph.D.	CEO & Director	2,59M	N/D	1960
Dr. John Climax Ph.D.	Founder & Independent Non-Executive Director	90k	N/D	1953
Mr. Brendan Brennan	Chief Financial Officer	1,07M	N/D	1979
Jonathan Andrew Curtain	Senior Vice President of Corporate & Commercial Finance	N/D	N/D	1976
Mr. Thomas N. O'Leary	Chief Information Officer	N/D	N/D	N/D
Mr. Diarmaid Cunningham	Chief Administrative Officer, General Counsel & Company Secretary	N/D	N/D	1975
Ms. Niamh Murphy	Director of Corporate Communications	N/D	N/D	N/D
Mr. David Green	Vice President of Marketing	N/D	N/D	N/D
Mr. Joe Cronin	Chief Human Resources Officer	N/D	N/D	N/D
Mr. Simon Holmes	President of Corporate Investments & Partnerships	N/D	N/D	1967

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Governance aziendale

L'ISS Governance QualityScore di ICON Public Limited Company al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.